Pilot study of intravenous contrast-enhanced cone beam CT in patients receiving radiotherapy
Study of IV Contrast on Patients Going Through Image Guided Radiation Therapy (IGRT) for Abdominal and Pelvic Cancer
Sponsor: NA
Enrolling: Male and Female Patients
IRB Number: AAAS0632
U.S. Govt. ID: NCT04199754
Contact: Mariamne Reyna: 212-342-5162 / mo2213@cumc.columbia.edu
Additional Study Information: The purpose of this study is to find out if giving intravenous (IV) contrast (a liquid that helps with the visibility of organs and blood vessels that is given through the vein with the use of a hollow needle) during a Cone Beam Computed Tomography (CBCT- a type of computerized X-ray) can help people who have image-guided radiation therapy (IGRT) for the treatment of abdominal and pelvic tumors. Cancers may include uterine cancer, pancreatic cancer, stomach cancer, colon and rectal cancer, liver cancer, and prostate cancer.
This study is closed
David Horowitz, MD
Do You Qualify?
Are you at least 18 years old? Yes No
Do you have a single kidney, transplanted kidney or kidney failure? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Mariamne Reyna